This Article Full Text Full Text (PDF) All Versions of this Article: 0008-5472.CAN-06-3383v1 67/5/2360    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Algar, E. M. Articles by Collins, F. Search for Related Content PubMed PubMed Citation Articles by Algar, E. M. Articles by Collins, F.

Paternally Inherited Submicroscopic Duplication at 11p15.5 Implicates Insulin-like Growth Factor II in Overgrowth and Wilms' Tumorigenesis

¹ Department of Pediatrics, University of Melbourne and Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia; Departments of ² Cytogenetics and ³ Clinical Genetics, Children's Hospital at Westmead, Westmead, New South Wales, Australia; and ⁴ Children's Hospital, University of Mainz, Mainz, Germany

Requests for reprints: Elizabeth M. Algar, Children's Cancer Centre, Royal Children's Hospital, Flemington Road, Parkville 3052, Victoria, Australia. Phone: 61-3-9345-6579; Fax: 61-3-9354-6524; E-mail: elizabeth.algar{at}rch.org.au.

Loss of imprinting at insulin-like growth factor II (IGFII), in association with H19 silencing, has been described previously in a subgroup of Beckwith-Wiedemann syndrome (BWS) patients who have an elevated risk for Wilms' tumor. An equivalent somatic mutation occurs in sporadic Wilms' tumor. We describe a family with overgrowth in three generations and Wilms' tumor in two generations, with paternal inheritance of a cis-duplication at 11p15.5 spanning the BWS IC1 region and including H19, IGFII, INS, and TH. The duplicated region was below the limit of detection by high-resolution karyotyping and fluorescence in situ hybridization, has a predicted minimum size of 400 kb, and was confirmed by genotyping and gene-dosage analysis on a CytoChip comparative genomic hybridization bacterial artificial chromosome array. IGFII is the only known paternally expressed oncogene mapping within the duplicated region and our findings directly implicate IGFII in Wilms' tumorigenesis and add to the mutation spectrum that increases the effective dose of IGFII. Furthermore, this study raises the possibility that sporadic cases of overgrowth and Wilms' tumor, presenting with apparent gain of methylation at IC1, may be explained by submicroscopic paternal duplications. This finding has important implications for determining the transmission risk in these disorders. [Cancer Res 2007;67(5):2360–5]

This article has been cited by other articles:

				K. Goodin, M. Chen, E. Lose, F. M. Mikhail, and B. R. Korf Advances in Genetic Testing and Applications in Newborn Medicine NeoReviews, July 1, 2008; 9(7): e282 - e290. [Abstract] [Full Text] [PDF]